Bisacodyl suppositories recalled nationwide due to improper storage
McKesson Medical-Surgical is recalling Bisacodyl suppositories stored outside label specifications. The FDA Class II recall affects 45 boxes distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving improper storage outside drug label specifications. No illnesses or injuries have been reported, and the recall is precautionary based on CGMP manufacturing practice deviations.
Plain-English summary
Bisacodyl suppositories (10 mg strength, 100 suppositories per box, Health Star brand) manufactured by McKesson Medical-Surgical Inc. are being recalled. The product is identified by NDC 57896-443-01 and part number 444-01-HST. Approximately 45 boxes were affected.
The product was stored outside the specifications listed on the drug label. This constitutes a deviation from Current Good Manufacturing Practice standards.
The affected product was distributed nationwide throughout the United States.
Consumers who have purchased this product or have questions about the recall should contact McKesson Medical-Surgical Inc. or the FDA for further information.
The recalled product
- Product
- BISACODYL (BISACODYL)
- Brand
- BISACODYL
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Laxative / OTC
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part# 444-01-HST
UPCs (1)
- 0357896444051
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27